DIVINCELL has developed a unique and patented peptide-based nanoparticle platform DIV’INTM able to deliver into the pathologic cell the appropriate therapeutics to fight or prevent diseases.
Concept
The DIV’INTM Nanocage technology is a versatile nanoparticulate system, enabling the protection, packaging and tissue or cell specificity of biomacromolecules. It is based on more than 20 years of experience in the field of nanotechnology and targeted delivery of macromolecules.
DIVINCELL have designed and selected amphipathic peptides able to form stable self-assembled nanoparticles with a wide range of macromolecules.
Our breakthrough technology combines highly versatile delivery capabilities of amphipathic peptides with innovative targeting and tissue release approaches to improve drug delivery to organs of interest without altering their physiological balance.